Download full-text PDF

Source
http://dx.doi.org/10.1177/1753193408104562DOI Listing

Publication Analysis

Top Keywords

non-infectious subcutaneous
4
subcutaneous emphysema
4
emphysema forearm
4
forearm 12-year-old
4
12-year-old schoolgirl
4
non-infectious
1
emphysema
1
forearm
1
12-year-old
1
schoolgirl
1

Similar Publications

To perform or not to perform fasciotomy? A rare case report.

Jt Dis Relat Surg

January 2025

Kayseri Şehir Eğitim ve Araştırma Hastanesi, Ortopedi ve Travmatoloji Kliniği, 38080 Kocasian, Kayseri, Türkiye.

Subcutaneous emphysema, caused by the presence of air or gas in subcutaneous tissues, can be infectious or noninfectious. A thorough clinical evaluation, including both physical examination and radiological imaging, is required to distinguish benign subcutaneous emphysema from necrotizing soft tissue infections. In this article, we report a 12-year-old female patient with benign subcutaneous emphysema of the upper extremity and highlight the importance of an accurate diagnosis to avoid unnecessary surgical intervention.

View Article and Find Full Text PDF

Efficacy and tolerability of subcutaneous repository corticotropin injection in refractory ocular inflammatory diseases.

J Ophthalmic Inflamm Infect

October 2024

Department of Ophthalmology, Byers Eye Institute, Stanford University, 2452 Watson Court Suite 200, 94303, Palo Alto, CA, USA.

Background: Repository corticotropin injection (RCI) has been suggested to exert immunomodulatory and anti-inflammatory effects in ocular inflammation. The index retrospective study aimed to evaluate the efficacy and tolerability of subcutaneous RCI in patients with active scleritis or uveitis.

Main Body: Medical records of patients who were diagnosed with different types of active scleritis or uveitis and received RCI for more than six months at a tertiary eye center were reviewed.

View Article and Find Full Text PDF

[Prevalence of dermatological manifestations in common variable immunodeficiency patients].

Rev Alerg Mex

June 2024

Médico adscrito, encargada de la Clínica de Inmunodeficiencias, Alergia e Inmunología Clínica. Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México.

Article Synopsis
  • The study aimed to estimate how common skin issues are among Mexican patients with common variable immunodeficiency (CVID).
  • It reviewed medical records of 36 patients and found that 70% experienced dermatological symptoms, with irritant contact dermatitis being the most prevalent.
  • The research highlights the importance of recognizing skin conditions in CVID patients due to their potential complications, like a higher risk of infections.
View Article and Find Full Text PDF
Article Synopsis
  • Adalimumab is being tested as a treatment for autoimmune non-infectious uveitis (ANIU) in a trial called ASTUTE, which aims to evaluate its effectiveness and cost-effectiveness for a broader range of patients than currently approved in the UK.
  • The trial is a multicenter, placebo-controlled study, where 174 participants who respond to a 16-week run-in phase will be randomized to receive either adalimumab or placebo, focusing on treatment failure and various outcomes like visual function and quality of life.
  • Ethical approval was obtained in June 2020, and the results of the trial will be shared at international conferences and published in peer-reviewed journals to ensure widespread dissemination among professionals and patients.
View Article and Find Full Text PDF

Cellulitis is an acute bacterial infection that affects the deep dermis and surrounding subcutaneous tissue. Although it is a common condition, it is often misdiagnosed because it can mimic a range of conditions that also cause inflamed, red, irritated and painful skin. Such misdiagnoses may lead to unnecessary hospital admissions and antibiotic overuse, with most alternative diagnoses being non-infectious.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!